about
Randomised controlled trial of video clips and interactive games to improve vision in children with amblyopia using the I-BiT systemShould there be a visual standard for ophthalmologists and other surgeons?Endothelial cells of tumor vessels: abnormal but not absent.Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trialDoes raised intraocular pressure begin in utero?Modelling uveal melanoma.The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction.Trends in eye cancer mortality among adults in the USA and England and WalesFalls and health status in elderly women following first eye cataract surgery: an economic evaluation conducted alongside a randomised controlled trial.Outcome of periocular sebaceous gland carcinoma.Basement membrane changes in capillaries of the ageing human retina.Evaluation and development of a novel binocular treatment (I-BiT™) system using video clips and interactive games to improve vision in children with amblyopia ('lazy eye'): study protocol for a randomised controlled trial.Why are new patients coming to the eye clinic? An analysis of the relative frequencies of ophthalmic disease amongst new patients attending hospital eye clinics in two separate locations.Determining patient preferences in the management of neovascular age-related macular degeneration: a conjoint analysisViews of glaucoma patients on provision of follow-up care; an assessment of patient preferences by conjoint analysis.Retinal detachment following anterior chamber lens implantation for the correction of ultra-high myopia in phakic eyes.An intralenticular foreign body and a clear lens.Axon deviation in the human lamina cribrosaEffects of single, short-term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: implications for the treatment of proliferative vitreoretinopathy.Response to Dr Yeo.Risks of adverse events with therapies for age-related macular degeneration: a response.Intracellular flow in optic nerve axons: a mechanism for cell death in glaucoma.Bilateral simultaneous central retinal vein occlusion secondary to hyperviscosity in Waldenstrom's macroglobulinaemia.Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD).Retinal oxygen distribution and the role of neuroglobin.A theoretical model to allow prediction of the CSF pressure from observations of the retinal venous pulse.Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration.Immunohistochemical techniques: the effect of melanin bleaching.Unique vascular phenotypes following over-expression of individual VEGFA isoforms from the developing lensSecond-eye cataract surgery in elderly women: a cost-utility analysis conducted alongside a randomized controlled trialA theory-driven qualitative study exploring issues relating to adherence to topical glaucoma medications.Transient vessel wall sheathing in acute retinal vein occlusionsInterstitial keratitis and iridoschisis in congenital syphilisUndefined high-power fieldsMicrovessel count predicts survival in uveal melanomaThe immunoalkaline phosphatase technique in immunohistochemistry: the effect of permanganate-oxalate melanin bleaching upon four final reaction productsUveal melanoma: is solar ultraviolet radiation a risk factor?A comparison of slit-lamp supported versus hand-held biometryAnterior hyaloidal fibrovascular proliferation after extracapsular cataract extraction in diabetic eyesCurrent indications for scleral contact lenses
P50
Q28589931-2C5583DF-1E53-4376-8437-EDB18D8822B6Q33604002-8C571B58-F97C-4FDF-910E-DAFE41425A2AQ34146273-DCC85A5B-B429-437C-A161-600CFA2B8977Q35224191-48BCC785-75BA-4E5C-9C79-D189B2BF7AA7Q35302473-E051E9BC-834A-4A50-8CC3-7BEC6945EE66Q35309796-4D1D34DE-369C-4B8B-AE1E-0E5E20614A78Q36081848-83974BD0-B031-44BA-8F6D-1885456D66D7Q36136523-001F0B43-170F-4094-AA2F-6670C8EEADB5Q36172338-1813F23F-13EF-4535-BE26-EBC3B2B02B28Q36290428-72C31180-B00D-4705-A4F8-3905E56CD3D1Q36860958-F0380684-8FBB-42AE-91F2-79F700D4E1D5Q36874072-5CDF5EA7-73D6-41E8-B3F1-4C718E0B3014Q36896083-1A164BAF-7A6D-4E05-B4DE-C00F509842F8Q36906875-7DB74D95-58E5-47E1-8178-513E294A40CCQ37229546-17DDF295-2DA6-44BA-864E-1CE9E4B7F688Q39693569-698EB5BF-15B0-4542-8DC3-22A3FED3381EQ39698167-50DBE74A-E040-40E6-8CB2-A29D779E7F27Q41953762-D1EEC78E-85A5-483C-85FA-7C5FB7421D71Q42072682-D7D6F297-309A-493B-AF48-69A3634FA2D6Q42446096-620DCE09-C6C9-4B7E-AD78-67FE511BAAE3Q45067875-5113AB6E-B591-448E-B56F-425D581E8E48Q46029796-92CCECAA-D937-4D8F-93CC-8ABFC04413B0Q46502626-4AAC5FFC-2567-4D7F-B1F7-972A8C56A3AFQ46742878-05CACCB7-CF8D-470D-9926-A8AFCE457E80Q50854203-019E47D7-7990-4971-A7B7-C74AFC3B1C3FQ51043046-FA519F73-2FA8-45C3-877C-43007F221E9FQ51082475-A250306A-8A36-4B22-8072-1176F6F73658Q54179691-6189CBD2-B1E4-441A-BAAA-9803855E1B96Q59565887-2FB8693C-05D2-4E88-8321-221F9F5891C2Q61764526-6A0D1243-DD4E-46D0-B844-E8BB29CBF35DQ64987651-309A00F1-2C59-4853-8FF6-6BDE43F35412Q67589767-08326A08-AE55-4C35-8996-A657B4990F83Q67907514-A36405DF-4E86-4DF1-9AB9-63B9B3202333Q70874584-42055F3F-63FB-4F1F-98C1-4BDCA8F2A885Q71170269-433098AA-F61F-4691-89FB-6CE430721B1AQ71397633-03A889B1-4A4E-46C1-944D-44C0B69B6A6DQ71494861-5B658006-7A02-4633-91B7-AED1E6C93F52Q71835349-FEE7089E-821B-4F02-B71B-47367C67C87BQ72071808-D7F832C8-372F-45FB-B322-030675DBCAFCQ72092991-A766D03B-8575-4427-8C5F-63D42DE748E1
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Alexander J. Foss
@en
Foss AJ
@ast
Foss AJ
@es
Foss AJ
@nl
type
label
Alexander J. Foss
@en
Foss AJ
@ast
Foss AJ
@es
Foss AJ
@nl
altLabel
Foss AJ
@en
prefLabel
Alexander J. Foss
@en
Foss AJ
@ast
Foss AJ
@es
Foss AJ
@nl
P31
P496
0000-0001-9649-0072